Autoimmune Diseases  >>  Toujeo (Long-acting Recombinant Human Insulin Analogue)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Toujeo (Long-acting Recombinant Human Insulin Analogue) / Sanofi
EDITION IV, NCT01683266 / 2012-001524-35: Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Checkmark From EDITION IV trial for diabetes
Dec 2013 - Dec 2013: From EDITION IV trial for diabetes
Completed
3
549
Japan, US, Canada, Europe
HOE901-U300 (Insulin glargine new formulation), Lantus (Insulin glargine)
Sanofi
Type 1 Diabetes Mellitus
09/13
03/14

Download Options